ArticleMolecular biology reports2026
Association of SIRT1 rs12778366 (T > C) polymorphism with reduced esophageal cancer risk: a case-control study from North India".
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe protein histone deacetylase silent mating-type information regulator 2 homolog 1 (SIRT1) expression has been linked to cancer prognosis. However, reports evaluating the impact of SIRT1 polymorphisms on esophageal cancer (EC) risk or prognosis are limited. The present study aimed to assess the association between SIRT1 rs12778366 polymorphism and esophageal cancer. MATERIALS AND
methodsThe SIRT1 rs12778366 polymorphism was evaluated by PCR-RFLP method in 244 EC patients and 244 healthy controls from Punjab, India. Odds ratios with 95% confidence intervals were used to assess the association of rs12778366 with EC risk.
resultsThe CC genotype (OR = 0.34, 95% CI: 0.12-0.97, p = 0.04) and the C allele (OR = 0.66, 95% CI: 0.47-0.92, p = 0.01) of the SIRT1 rs12778366 polymorphism were significantly associated with a reduced risk of esophageal cancer.
conclusionPrevious studies have linked the SIRT1 rs12778366 polymorphism to susceptibility in breast, colorectal, and pituitary tumors, but its role in esophageal cancer has been minimally explored. In the present study, the CC genotype and C allele of SIRT1 rs12778366 were associated with a reduced risk of esophageal cancer in a North Indian population.
Indexed as
Identifiers
42334702What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.